Literature DB >> 16327872

Cardiac risk and schizophrenia.

Ripu Jindal, Erin M MacKenzie, Glen B Baker, Vikram K Yeragani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16327872      PMCID： PMC1277021     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  38 in total

1.  Alterations of autonomic cardiac control in anorexia nervosa.

Authors:  T Rechlin; M Weis; C Ott; F Bleichner; P Joraschky
Journal:  Biol Psychiatry       Date:  1998-03-01       Impact factor: 13.382

2.  Diminished cardiac vagal tone in schizophrenia: associations to brain laterality and age of onset.

Authors:  D Malaspina; G Bruder; G W Dalack; S Storer; M Van Kammen; X Amador; A Glassman; J Gorman
Journal:  Biol Psychiatry       Date:  1997-03-01       Impact factor: 13.382

3.  Metabolic changes associated with antipsychotic use.

Authors:  Joseph A Lieberman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

4.  Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records.

Authors:  V K Yeragani; E Sobolewski; G Igel; C Johnson; V C Jampala; J Kay; N Hillman; S Yeragani; S Vempati
Journal:  Psychiatry Res       Date:  1998-03-20       Impact factor: 3.222

Review 5.  Antipsychotic drugs and QT prolongation.

Authors:  Claudia Stöllberger; Johannes O Huber; Josef Finsterer
Journal:  Int Clin Psychopharmacol       Date:  2005-09       Impact factor: 1.659

6.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

7.  QT interval prolongation as predictor of sudden death in patients with myocardial infarction.

Authors:  P J Schwartz; S Wolf
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

8.  Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval.

Authors:  P T Nguyen; M M Scheinman; J Seger
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

9.  Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects.

Authors:  Jong-Hoon Kim; Sang Hoon Yi; Cheol Sung Yoo; Seung Ae Yang; Se Chang Yoon; Kyu Young Lee; Yong Min Ahn; Ung Gu Kang; Yong Sik Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-03       Impact factor: 5.067

10.  Heart rate variability in acute psychosis.

Authors:  Minna Valkonen-Korhonen; Mika P Tarvainen; Perttu Ranta-Aho; Pasi A Karjalainen; Juhani Partanen; Jari Karhu; Johannes Lehtonen
Journal:  Psychophysiology       Date:  2003-09       Impact factor: 4.016
View more
  9 in total

1.  Analysis of heart rate variability during auditory stimulation periods in patients with schizophrenia.

Authors:  Saime Akdemir Akar; Sadık Kara; Fatma Latifoğlu; Vedat Bilgiç
Journal:  J Clin Monit Comput       Date:  2014-05-16       Impact factor: 2.502

2.  The phrenic component of acute schizophrenia--a name and its physiological reality.

Authors:  Karl-Jürgen Bär; Tobias Rachow; Steffen Schulz; Katharina Bassarab; Stefanie Haufe; Sandy Berger; Kathrin Koch; Andreas Voss
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

3.  Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis.

Authors:  Maria Fe Barcones; Karina Soledad MacDowell; Borja García-Bueno; Miquel Bioque; Leticia Gutiérrez-Galve; Ana González-Pinto; Maria José Parellada; Julio Bobes; Miguel Bernardo; Antonio Lobo; Juan Carlos Leza
Journal:  Int J Neuropsychopharmacol       Date:  2018-05-01       Impact factor: 5.176

4.  Oxidative Stress Impact on the Transcriptome of Differentiating Neuroblastoma Cells: Implication for Psychiatric Disorders.

Authors:  Behnaz Khavari; Ebrahim Mahmoudi; Michael P Geaghan; Murray J Cairns
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

5.  Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven review.

Authors:  Rébecca Robillard; Naomi L Rogers; Bradley G Whitwell; Tim Lambert
Journal:  Clin Psychopharmacol Neurosci       Date:  2012-04-30       Impact factor: 2.582

Review 6.  Minimizing cardiovascular adverse effects of atypical antipsychotic drugs in patients with schizophrenia.

Authors:  Fadi T Khasawneh; Gollapudi S Shankar
Journal:  Cardiol Res Pract       Date:  2014-02-04       Impact factor: 1.866

7.  Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment.

Authors:  Parvin Kumar; Paschalis Efstathopoulos; Vincent Millischer; Eric Olsson; Ya Bin Wei; Oliver Brüstle; Martin Schalling; J Carlos Villaescusa; Urban Ösby; Catharina Lavebratt
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

8.  Sudden Cardiac Arrest in a Young Population: Not So Unpredictable.

Authors:  Dianne L Atkins
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

9.  Heart and Brain Interaction of Psychiatric Illness: A Review Focused on Heart Rate Variability, Cognitive Function, and Quantitative Electroencephalography.

Authors:  Wookyoung Jung; Kuk-In Jang; Seung-Hwan Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-11-20       Impact factor: 2.582
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.